HIV/AIDS
Aethlon Medical Discloses Strategy to Commercialize Hemopurifier in India
Published in AIDS Weekly, July 2nd, 2007
Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that it will pursue the commercialization of its 1st generation Hemopurifier(R) in India during the course of the next year. The strategy to initiate commercialization in India corresponds with Aethlon's international objectives and will parallel the company's effort to advance the Hemopurifier(R) as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats in the United States. "We are going to implement strategies that offer the greatest likelihood of transitioning our science from the labs and into the marketplace," stated Aethlon Chairman & CEO, James A. Joyce. "Our plans in India will reinforce our goal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-07-02)
More Articles from AIDS Weekly
- HIV/AIDS
Drug warning prompts treatment changes for those infected with hepatitis B and HIV - HIV/AIDS
Male circumcision overstated as prevention tool against AIDS - HIV/AIDS
Researchers pit novel version of common virus against cancer - HIV/AIDS
Studies identify more effective treatment for malaria control during pregnancy in Africa - HIV/AIDS
Ultra deep sequencing identifies HIV drug resistance at early stage - HIV/AIDS Co-Infection
Award winning book co-edited by Rutgers College of Nursing Dean updated with new information - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
